Proteon extends Lonza contract to 2029 ahead of potential BLA filing
Lonza has inked a long-term contract extension for the commercial supply of Proteon’s lead development candidate as its Ph III clinical trial nears completion.
Archives for May 9, 2018
Roche’s immunotherapy combo receives FDA priority review
Roche’s immunotherapy combination has received priority review after Phase III trial results showed potential to provide significant survival benefit in the initial treatment of NSCLC.
PlantForm receives European patent for tobacco plant-based platform
The patent will help PlantForm Corporation continue to advance its platform for manufacturing antibody and protein drugs, as the company looks to bring products to market, says CEO.
Novasep invests €10m in commercial aseptic fill/finish facility
Novasep is investing €10m ($11.88) in a commercial fill/finish facility for viral vectors, mAbs, and other low-volume biologics, as part of its plan to double in size by 2022.
The Golden Ticket: Sanofi, Meditope initiate research collaboration to explore bioconjugation tech
Sanofi has awarded Meditope Biosciences a BioLabs’ “Golden Ticket” to support the development of its bioconjugation platform and create new antibody-based therapeutic constructs.